Zenara Pharma, a fully-owned subsidiary of the city-based Biophore India Pharmaceuticals, on Friday announced that it has launched generic Paxlovid (Nirmatrelvir and Ritonavir) tablets in a combi pack as a treatment option for patients with mild to moderate symptoms of Covid-19. A press release from the drug maker said Zenara Pharma has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market this product last month. The product, which will be sold under the brand name 'Paxzen,' is being manufactured at Zenara's US FDA and EU approved state-of-the-art facility in Hyderabad, it said. Pfizer's Paxlovid has been approved by US FDA for COVID treatment. The product will be sold at a Maximum Retail Price of Rs 5,200 per box, equivalent to one full course of treatment per patient, and contains 20 tablets of Nirmatrelvir 150ml and 10 Tablets of Ritonavir 100mg. Jagadeesh Babu Rangisetty, Co-founder and Managing Director at Zenara Pharma, s
While the common symptoms of Covid, include headache, fever, cough, cold, throat irritation and body ache, experts have now warned of newer symptoms
A recent investigation published by the British Medical Journal revealed that long COVID patients are travelling abroad to seek expensive blood washing treatment
Reviews Covid-19 situation in nine states where test positivity rates have been rising
States start compiling need for additional doses, Centre seeks 50 mn doses from GAVI
Chhattisgarh Health Minister TS Singh Deo on Saturday informed he has tested positive for COVID-19. This is the third time the minister, who returned from Delhi on Friday night, has contracted the infection. "After returning from Delhi, I got my COVID-19 test done here in which I tested positive for the coronavirus. Right now I am fine and as per suggestions of doctors, I am complying with the home isolation protocols," Singh Deo tweeted. Earlier, Singh Deo had tested positive in January this year and March last year. As on Friday, Chhattisgarh has a COVID-19 caseload of 11,53,552, including 14,036 deaths, while the active tally is 643.
However, experts say that Covaxin induces a wider immune response and thus antibody production against the spike protein may be less intense
The US Food and Drug administration's (FDA) advisory committee has recommended that regulators authorise Novavax's protein-based Covid shot.
With the count of daily new coronavirus cases in Delhi fluctuating over the last few days, experts on Thursday said the city will keep witnessing such trends for fairly long
Delhi reported 1,422 fresh COVID-19 cases and zero fatality due to the viral disease on Sunday, while the positivity rate was recorded ta 5.34 per cent, according to the health department.
Social media platforms have falsely linked the Covid vaccine with the recent spike in unexplained hepatitis in children across several countries, including the UK, the US and many others.
Countries that attempted to control transmission with stricter restrictions had worse mental health outcomes than those which did not, according The Lancet Public Health journal.
Covid-19 infections in Spain have risen sharply following the elimination of the mandatory wearing of face masks indoors, data published by the Ministry of Health showed.
Millions of unused Covid-19 doses in the United States are set to go wasted as the country's vaccination rates continued to decline amid an uptick of new infections.
More than 1.92 billion vaccine doses have been provided to States and Union Territories till date, informed the Ministry of Health and Family Welfare
More than 201.6 mn unutilised COVID-19 vaccine doses are still available with States and Union Territories (UTs) to be administered, informed the Ministry of Health and Family Welfare on Thursday
Scientists are developing a chewing gum laced with a plant-grown protein that serves as a "trap" for the SARS-CoV-2 virus, which causes COVID-19, reducing viral load in saliva
Researchers treated 739 randomly selected Brazilian COVID-19 patients with fluvoxamine, with another 733 receiving a placebo, between January 15 to August 6 of this year.
With 16,156 people testing positive for coronavirus infection in a day, India's total tally of Covid-19 cases rose to 3,42,31,809
Researchers have designed a synthetic defective SARS-CoV-2 that can interfere with growth of real virus, potentially leading to the extinction of both Covid-19 causing pathogen and the artificial one